Stories, blogs and articles

Filter By
Topics

All

About us

Artificial Intelligence

Biotech

Corporate Sustainability

Digitization

Disease Awareness

Fertility

Financials and Company Performance

Gene Editing

Growth Markets

Healthcare

High Tech Materials

Immunology

Lab Materials

Life Sciences and Lab Support

OLED Technologies

Oncology and Immuno-Oncology

Partnerships

People and Employee Development

Pharma and Biopharma End-to-End Manufacturing

Scientific Research

Technology

Well Being

Types

All

Perspectives

Scientific Research

Trends and Innovations

Updates from our Company

Reset All

Showing 1 - 10 of 65 results

Quarterly Statement Q3/2021

Our Q3 2021 results will be published on November 11, at 7 a.m. CEST. Our conference call for the media will take place at 9:30 a.m. CEST, and the conference call for analysts at 2 p.m. CEST.

Annual General Meeting

Merck KGaA, Darmstadt, Germany held its AGM 2021 on April 23. The company made use of the possibilities afforded by the German legislator because of the coronavirus pandemic and conducted the shareholders’ ...

Annual General Meeting 2021

Merck KGaA, Darmstadt, Germany held its AGM 2021 on April 23. The company made use of the possibilities afforded by the German legislator because of the coronavirus pandemic and conducted the shareholders’ ...

Quarterly Statement Q1/2022

Our Q1 2022 results will be published on May 12, at 7 a.m. CEST. Our conference call for the media will take place at 9:30 a.m. CEST, and the conference call for analysts at 2 p.m. CEST.

Quarterly Statement Q2/2022

Our Q2 2022 results will be published on August 4, at 7 a.m. CEST. Our conference call for the media will take place at 9:30 a.m. CEST, and the conference call for analysts at 2 p.m. CEST.

OLED

The future has never been brighter or more colorful.

Envisioning Tomorrow

Making a positive difference: Our work is fueled by the belief that science is a force for good. That’s why we’re focusing our most innovative R&D on issues that have world-changing potential.

REDIRECT-AI POWERED NEUROSTIMULATORS

Enable next generation treatment options with highly selective vagus nerve recording and stimulation devices in conjunction with remote patient monitoring systems.

AI POWERED NEUROSTIMULATORS

Enable next generation treatment options with highly selective vagus nerve recording and stimulation devices in conjunction with remote patient monitoring systems.

Bioelectronics

The right impulses to treat or prevent diseases: Bioelectronic medical devices could enable targeted treatment of chronic diseases and potentially reduce side effects by selectively stimulating distinct nerves.

1

2

3

4

5

6

7

1

2

3

4

5

Next